A bacterium is a prokaryote: it has no membrane-bound nucleus, no mitochondria, and no endoplasmic reticulum. Its chromosome is a single circular DNA molecule packed into the nucleoid, and its ribosomes are 70S particles made of a 50S and a 30S subunit. Outside the cytoplasmic membrane sits the peptidoglycan cell wall, a mesh of glycan strands cross-linked by short peptides. Gram-positive bacteria have a thick peptidoglycan layer; Gram-negative bacteria have a thinner layer plus an outer membrane containing lipopolysaccharide.
Each of these features has a counterpart in human cells that is structurally different. Human ribosomes are 80S (60S plus 40S). Human cells have no peptidoglycan at all; their structural support comes from a plasma membrane and, in tissues, from a collagen-based extracellular matrix. Human DNA replication uses different gyrase-like enzymes, and humans obtain folate from the diet rather than synthesizing it.
These differences are what make selective toxicity possible: a drug can be designed to fit a bacterial molecule that has no close human analogue, so the drug interferes with the bacterium while leaving the human cell's equivalent process alone.